<DOC>
	<DOCNO>NCT01133080</DOCNO>
	<brief_summary>Double - Blind , Randomized , single center study . The purpose study assess feasibility minocycline vs. placebo , add atypical antipsychotic medication , positive symptom adult suffer schizophrenia .</brief_summary>
	<brief_title>Minocycline Adjunctive Therapy Schizophrenia : Randomized Controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Men woman 2065 year age . Primary DSMIV diagnosis Schizophrenia base SCID schizophrenia confirm two senior psychiatrist . Patients score `` moderate '' ( 4 ) high least three seven positive item PANSS Initiated treatment atypical antipsychotic medication . Capable willing provide inform consent Able adhere treatment schedule Able read , hear , write speak local language . Has sign write informed consent participate study Patients acute , unstable , significant , untreated medical illness besides schizophrenia include alcohol drug dependence , depression . Current suicidal ideation history suicide attempt past 3 year Known suspected pregnancy woman childbearing potential use medically accept form contraception engage sexual intercourse . woman breastfeed Subjects take known contraindication minocycline treatment . Subjects receive treatment minocycline Î²lactam antibiotic precede half year study entry . Subjects compulsory hospitalization .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>